Both NR2F1-AS1 and ABCC1 are upregulated in these cultured oxaliplatin-resistant HCC cells, suggesting that ABCC1 might function as a direct target of NR2F1-AS1 in regulating oxaliplatin resistance [106,107]. The gene discussed is NR2F1; the disease is hepatocellular carcinoma.